Excludes commercial-in-confidence projects.
Research outputs for the last seven years are shown below.
Open access indicates that an output is open access.
Shanmuganathan, N, Wadham, C, Thomson, D, Shahrin, NH, Vignaud, C, Obourn, V, Chaturvedi, S, Yang, F, Feng, J, Saunders, V, Kok, CH, Yeung, D, King, RM, Kenyon, RR, Lin, M, Wang, P, Scott, H, Hughes, T, Schreiber, AW & Branford, S 2022, 'RNA-based targeted gene sequencing improves the diagnostic yield of mutant detection in chronic myeloid leukemia', Journal of Molecular Diagnostics, vol. 24, no. 7, pp. 803-822.
External engagement & recognition
|Novartis Pharmaceuticals||UNITED STATES|
|Royal Adelaide Hospital||AUSTRALIA|
|South Australian Health and Medical Research Institute (SAHMRI)||AUSTRALIA|
|University of Adelaide||AUSTRALIA|
|University of South Australia||AUSTRALIA|
Supervisions from 2010 shown
|Thesis title||Student status|
|Enhanced bioinformatics and machine learning for improved risk stratification and outcome prediction in chronic myeloid leukaemia||Current|